Weight and Fertility: What the Numbers Actually Mean

You have been told to lose weight before treatment, or you have read that a BMI above 30 cuts your chances in half. You may have PCOS and a long, complicated relationship with weight. You are reading this hoping for honesty rather than a lecture, and that is what I want to give you. This is the version of the weight and fertility conversation I have in clinic, with the numbers, the policy thresholds, and the realistic targets in their right places.

The short version. Weight affects fertility in real, measurable ways at the extremes of low and high. The numbers most people quote ("you must be under BMI 30 to access IVF") are policy thresholds, not biological cliffs. What actually moves outcomes in the data is metabolic health and a sustained five to ten percent change in body weight where weight is elevated, not arrival at a goal number. This post is the longer version of those two sentences.

What the weight and fertility data actually say

I want to lay out the ranges plainly so they sit in their own space, separate from the conversation about what to do about them.

Underweight (BMI under 18.5): functional hypothalamic amenorrhoea is more common at low BMI; ovulation rates fall; IVF live birth rates are lower. This is the population invisible in most "fertility and weight" content, which tilts toward the higher end. Underweight matters too, and the prescription is restoration of weight and energy availability, not optimisation of an already-low number.

Healthy weight (BMI 18.5 to 24.9): no fertility cost attributable to weight as such. Other factors (PCOS, thyroid, age, partner factors) are the relevant variables.

Overweight (BMI 25 to 29.9) and obesity (BMI 30 and above): longer time to pregnancy in observational data, with the slope steepest above BMI 35. IVF live birth rates are typically reduced by something in the range of 10 to 30 percent relative to BMI 18.5 to 24.9, with substantial variation by study and population. PCOS amplifies the effect of weight on ovulation. The ASRM committee opinion on obesity and reproduction summarises this evidence carefully and emphasises that the effect is dose-dependent and that the higher BMI categories carry the largest absolute risk.⁴

Male partner BMI: Sermondade and colleagues' meta-analysis of BMI in relation to sperm count found that BMI of 30 or above in the sperm-producing partner was associated with significantly lower sperm concentration and total count compared with normal-weight men.¹ Weight is a couples' variable, not a female-partner one.

Those are population averages. They tell you a risk shift across a population; they do not predict your individual outcome.

BMI is a blunt instrument

I want to spend a paragraph on this because the BMI cutoff is the number that ends up doing most of the work in fertility-and-weight conversations, and it deserves the criticism it gets.

BMI does not distinguish muscle from fat. A muscular athlete and a sedentary person can share a BMI. BMI does not tell you where the fat sits. Visceral fat (the metabolically active fat around the abdominal organs) is the meaningful variable for insulin resistance and reproductive endpoints. A person with a "normal" BMI can have a metabolically unfavourable visceral pattern. BMI was derived from a population that was disproportionately white European, and its cutoffs perform poorly in some other populations.

What matters more, biologically, is metabolic health. Waist circumference, fasting insulin, fasting glucose, HbA1c, and lipid panel give a much better picture of the variables that influence fertility than the number on a scale does. If your BMI is between 25 and 30 and your metabolic markers are clean, the fertility-relevant question is whether you have PCOS, thyroid disease, or other contributors. The question is not whether you "should lose weight." If your BMI is between 25 and 30 and your insulin and HbA1c are elevated, the metabolic markers are the thing to work on. Weight change tends to follow.

Why clinics use BMI thresholds anyway

It is fair to ask why, given all that, your clinic uses a BMI cutoff at all. The answer is administrative as much as biological.

NHS-funded IVF cycles in many UK regions, and many anaesthesia protocols around the world, use BMI cutoffs (commonly 30 or 35) for safety and resource-allocation reasons. Anaesthetic risk in retrieval procedures rises with BMI; obstetric risk in any resulting pregnancy rises with BMI; success rates per cycle fall with BMI, which matters when the pool of funded cycles is finite. NICE guidance and many UK Trust policies set a BMI ceiling for funded cycles, and US clinics often set their own. These are administrative thresholds with biological rationale, not biological cliffs.⁵

The practical implication is that you can sometimes negotiate or contextualise these thresholds with your team based on individual labs and history. "My BMI is 32, but my A1c is 38 mmol/mol, my insulin is 6, and my lipids are clean" is a different clinical picture from "my BMI is 32 and my A1c is 50 with pre-diabetes." A good clinic will sometimes treat those differently. Ask the question directly.

The number that actually moves outcomes

If I had to name one number in this post, it would be 5 to 10 percent.

A 5 to 10 percent reduction in body weight in people with elevated BMI and PCOS has the strongest evidence base for restoring ovulation, improving insulin sensitivity, and improving IVF outcomes. Legro and colleagues' randomised trial of preconception interventions in infertile women with PCOS showed that lifestyle-driven weight loss in this range improved ovulation and pregnancy outcomes.³ The 2023 International Evidence-based PCOS Guideline specifically endorses 5 to 10 percent as the target.² Best, Avenell, and Bhattacharya's systematic review of weight-loss interventions for fertility found that interventions reaching this magnitude consistently improved fertility outcomes.⁶ Smaller losses had inconsistent effects, and pushing past 10 percent was not necessary for the reproductive benefit.

That is a meaningful but small target in absolute terms. For someone at 90 kg, 5 to 10 percent is 4.5 to 9 kg. For someone at 110 kg, it is 5.5 to 11 kg. Past 10 percent, additional gains accrue more slowly and require sustained effort. The reproductive payoff plateaus, which means there is no medical reason to aim for "normal" BMI before trying.

What "lose weight before TTC" should actually mean

If your clinician has told you to lose weight before starting treatment, the conversation worth having is what specifically they mean. Lose weight to what number? For what reason? With what supports?

The clinical answer that is supported by the data is: lose enough to improve metabolic markers, not enough to hit an arbitrary number. Build a dietary and movement pattern you can sustain through pregnancy and postpartum, because the goal is durable health, not a brief reduction. Aim for a slow rate (0.25 to 0.5 kg per week is typical and sustainable), not a crash. Crash diets and very-low-calorie protocols in the 90 days immediately before conception are not preconception-appropriate, both because they stress the endocrine system and because the regain pattern after very-low-calorie weight loss is steep.

For the PCOS-specific approach, see losing weight with PCOS.

A note on GLP-1 medications

Many readers of this post in 2026 are either on a GLP-1 receptor agonist (semaglutide, liraglutide, tirzepatide) or considering one. The honest position from the preconception evidence base is this.

GLP-1 agonists produce significant weight loss in adults with elevated BMI, with or without diabetes. They have plausible benefits for PCOS-associated metabolic dysfunction. Their specific use in preconception PCOS is an active area of investigation, and clinical guidelines are still catching up to the prescribing reality.

The current consensus is that GLP-1 agonists should be stopped before conception, typically at least 2 months ahead of trying, because there is not enough safety data in pregnancy and there is some animal-study signal of concern. If you are on a GLP-1 and planning to try in the next 6 to 12 months, this is the specific conversation to have with the prescriber now, not on Day 1 of trying. There is a real timing question (when to stop, how much regain to expect, how to sustain the changes after stopping) and it benefits from being planned rather than improvised.

When weight is not the lever

Some readers arrive at this post having been told to lose weight when weight is not actually the relevant variable in their case. I want to name those scenarios because they are common.

A person of healthy weight with PCOS still needs the metabolic workup. Thin does not mean metabolically clear (see PCOS, insulin resistance, and fertility). The PCOS treatment plan does not change just because the BMI is normal.

A person with regular cycles, normal metabolic labs, and a BMI of 27 to 29 may be told to "lose weight" reflexively. The question worth asking the clinician is what specifically they expect to improve with weight loss in your individual case, and whether there is a higher-yield variable to address first.

A person at the underweight end of the spectrum has the inverse problem. Addressing the underweight is the priority, and any further weight loss is contraindicated.

A person with thyroid disease, varicocele in the partner, or unaddressed PCOS is being told that weight is the issue because weight is the visible variable; the actual underlying contributor is something else. Treating the underlying contributor often does more for fertility than the weight change would have.

What the clinic conversation should sound like

If you are walking into a fertility consultation with weight on the agenda, these are the questions I would want a patient to ask.

"What is your clinic's BMI threshold for funded treatment, and is there any flexibility based on individual metabolic markers?"

"Are there metabolic markers I should improve regardless of weight, and which ones?"

"Given my age and history, what is a safe rate of weight loss in the 3 to 12 months before we start trying?"

"Do you offer a dietitian referral or a structured lifestyle programme? Is bariatric or medical weight-loss support available if relevant?"

"Given my history, is there an argument for starting treatment in parallel with the lifestyle work rather than waiting until I reach a weight target?"

Good clinics have answers to these. If your clinic only has "lose weight" as a response, that is information worth having too.

What to watch out for

There are situations that overlap with TTC where weight management gets more complicated.

Bariatric surgery before TTC: most guidelines recommend 12 to 18 months of weight stability post-operatively before conception. Nutrient deficiencies (B12, folate, iron, calcium, vitamin D) need monitoring through the procedure and into pregnancy. If bariatric surgery is on your timeline, the conception plan stretches accordingly.

GLP-1 agonists in the trying window: discussed above. Plan the stop ahead of time.

Disordered eating in TTC populations: disordered eating is meaningfully under-recognised in fertility populations and is amplified by the focus on weight that the field carries. If tracking food has escalated into restriction, if rituals around eating are tightening, or if the scale is dictating your day, please ask for help. Eating disorders are treatable conditions, and pregnancy is not a safe context in which to leave them untreated.

Common worries: what is normal, what is a red flag

A few specific things I hear in clinic.

"Hair loss with rapid weight loss." Slow down the rate. Rapid weight loss precipitates telogen effluvium in many people, and the answer is a slower trajectory and adequate protein and iron. If it persists, see a clinician.

"My cycle disappeared once I started dieting." That is a sign you are restricting too hard. Increase energy intake, particularly carbohydrates and fats, and the cycle usually returns over weeks to months.

"I lost 5 percent and nothing changed in my cycle." Give it 3 to 6 months. PCOS-associated ovulation can take time to resume after metabolic improvement, and the cycle is often a lagging indicator. If nothing has changed by 6 months at a sustained 5 to 10 percent reduction, the conversation is whether ovulation induction (letrozole, typically) is now the right next step.

What to do this week

Concrete and proportionate.

1. Stop weighing yourself daily if you have been doing that. A weekly or fortnightly weight is more informative and less destabilising.
2. Write down 5 percent and 10 percent of your current body weight, in kilograms. Those are your targets, not BMI 25.
3. Pick one sustainable dietary change you can imagine doing for a year. Protein and fibre before carbohydrate at meals is a high-yield one for PCOS. A daily 30-minute walk after dinner is the highest-yield movement intervention.
4. Book the labs that actually matter for your case: HbA1c, fasting insulin and glucose, TSH, ferritin, vitamin D. Lipid panel. The numbers that drive the metabolic conversation are these, not weight in isolation.
5. If you are on a GLP-1 agonist or considering one, book the conversation with your prescriber about the trying-window plan.
6. If the language around your body has been punishing, take that seriously. Therapy that addresses weight stigma and disordered eating is part of fertility care, not separate from it.

When to involve your clinician

• BMI of 35 or above with PCOS and anovulation. Discuss medication options (metformin, GLP-1, where appropriate), structured programme support, and possibly a bariatric pathway alongside the trying timeline.
• BMI under 18.5 with TTC plans. Ask for a dietitian and consider an HPA/HPG axis workup.
• History of an eating disorder. Refer to a clinician familiar with the area before starting any structured weight protocol.
• Rapid weight change in either direction without an obvious cause. Thyroid disease, Cushing's syndrome, and other endocrine conditions can present this way and warrant investigation.
• Age 35 or older with weight as the named barrier to treatment. The fertility cost of delaying treatment 12 months to lose weight needs to be weighed against the benefit. Sometimes parallel paths (starting ovulation induction while continuing the lifestyle work) is the right call. Ask the question.

The body you bring to TTC is the body that gets you to a pregnancy if one happens. The weight and fertility conversation is not about punishment of that body. It is about small, sustainable changes to the metabolic engine that runs underneath it.

What's next

• If PCOS is part of your picture: PCOS, insulin resistance, and fertility
• If you want the realistic weight-loss approach for PCOS specifically: losing weight with PCOS
• If you want the dietary pillar: the Mediterranean diet and TTC and the evidence behind the fertility diet
• If exercise dosing is the next question: exercise and TTC, how much is too much
• If sleep and stress are also on the list: sleep, stress, and fertility
• If a cycle just did not work and the weight conversation is layered with that grief: when a cycle does not work, the feelings

Sources

1. Sermondade N, Faure C, Fezeu L, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Human Reproduction Update 2013;19(3):221-231. https://doi.org/10.1093/humupd/dms050
2. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
3. Legro RS, Dodson WC, Kris-Etherton PM, et al. Randomized controlled trial of preconception interventions in infertile women with PCOS. Journal of Clinical Endocrinology & Metabolism 2015;100(11):4048-4058. https://doi.org/10.1210/jc.2015-2778
4. Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertility and Sterility 2021;116(5):1266-1285. https://doi.org/10.1016/j.fertnstert.2021.08.018
5. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment (CG156). NICE; 2013 (updated 2017). https://www.nice.org.uk/guidance/cg156
6. Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Human Reproduction Update 2017;23(6):681-705. https://doi.org/10.1093/humupd/dmx027
7. Pasquali R, Patton L, Gambineri A. Obesity and infertility. Current Opinion in Endocrinology, Diabetes and Obesity 2007;14(6):482-487. https://doi.org/10.1097/MED.0b013e3282f1d6cb